Corix Bioscience Inc CXBS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.25
- Bid/Ask
- — / —
- Market Cap
- $27.34
- Volume/Avg
- 4,059 / 4,530
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2
- Website
- http://www.corixbioscience.com
Valuation
|
Metric
|
CXBS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CXBS
Financial Strength
|
Metric
|
CXBS
|
|---|---|
Quick Ratio | 0.46 |
Current Ratio | 5.11 |
Interest Coverage | −10.51 |
Quick Ratio
CXBS
Profitability
|
Metric
|
CXBS
|
|---|---|
Return on Assets (Normalized) | −40.10% |
Return on Equity (Normalized) | −96.74% |
Return on Invested Capital (Normalized) | −38.05% |
Return on Assets
CXBS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Jtftmykbpd | Slcdf | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Vbdlwljp | Dlzllx | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Szxkfzb | Lzzj | $41.4 Bil | |||
| Viatris Inc
VTRS
| Yqbssmq | Zfkq | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Rbmzfmgm | Hzh | $13.7 Bil | |||
| Catalent Inc
CTLT
| Swgczngr | Tczpr | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Rbqwsjd | Rngf | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kzwgfyzsl | Kxwtcs | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Zymnzqrmv | Dygyn | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Cfhkrlqkv | Dsxq | $2.7 Bil |